Large-scale testing (Phase 3)Study completedNCT05818709
What this trial is testing
Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants
Who this might be right for
Facial Volume Deficit
AbbVie 61
Showing 20 of 21 results